Uncategorized

Pro Medicus Limited (ASX:PME), a leading player in healthcare informatics, has announced a significant five-year contract extension valued at a minimum of $32 million with a prominent Australian radiology network. This extension pertains to the company’s Radiology Information System (RIS) product, Visage RIS. Dr Sam Hupert, CEO of Pro Medicus, stated, “This contract extension cements

Titomic Limited (ASX:TTT) has announced the completion of an equity placement, raising $30m to fund its expansion into the United States. The placement, priced at $0.12 per share, garnered strong support from both existing and new investors, prompting the company to increase its initial target from $25m. The funds will primarily support the establishment of

Clarity Pharmaceuticals (ASX:CU6) has reported significant developments in its SECuRE trial, which is evaluating the efficacy of 67Cu-SAR-bisPSMA for the treatment of prostate cancer. The third participant in cohort 4, a 93-year-old man with over 26 years of prostate cancer history, has completed the Dose Limiting Toxicity (DLT) period after receiving two doses of the

Chris Gosselin, CEO of Australian Fund Monitors, speaks to Nichols Chaplin, Director and Portfolio Manager at Seed Funds Management. Nicholas shares insights on APRA’s plan to phase out additional tier one bonds, which could destabilise the banking sector and impact retail investors.

To register for Friday’s webinar click here. Nyrada Inc (ASX:NYR) has successfully completed the final GLP safety study for its lead candidate, NYR-BI03. The company is now finalising its regulatory submission to the Human Ethics Research Committee (HREC), a key step toward starting its first-in-human Phase I clinical trial, expected to begin in Q4 2024.

Rita Gatt, National Lead Partner – Regulation, Security and Risk at Deloitte, discusses the revolutionary potential of quantum computing. Stef Winwood: Hi. My name is Stef Winwood from BluGlass (ASX:BLG), on behalf of Finance News Network today, and joining me today is Rita Gatt, who is a Partner at Deloitte serving as the National Lead

Australian shares fell, following losses on Wall Street, driven by reduced demand for natural resource-related assets. At 11:55am, the S&P/ASX 200 is 0.3 per cent lower at 8,293.30. The SPI futures are pointing to a fall of 26 points. Best and worst performers The best-performing sector is Financials, up 0.27 per cent. The worst-performing sector

Bapcor Limited (ASX:BAP), an ASX-listed leader in the automotive aftermarket industry, is undergoing significant changes under its new Executive Chair and CEO, Angus McKay, who stepped into the role eight weeks ago. The CEO emphasised the company’s robust position, stating, “Bapcor is a strong and well-positioned business in the resilient auto aftermarket industry. I believe

Engineering services company Monadelphous Group (ASX:MND) has announced a series of new contracts and extensions valued at approximately $160 million. These deals span several key mining and industrial sectors across Western Australia. Among the awards, Monadelphous secured a pair of one-year contract extensions with Rio Tinto (ASX:RIO) for fixed plant maintenance and capital projects at